Epilepsy market analysis of epidemiology, pipeline therapies and key companies working in the market

DelveInsight’s “Epilepsy- Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of epilepsy, historical and forecast epidemiology, and epilepsy market trends in the US, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

by DelveInsight Epilepsy – Market Overview, Epidemiology and Market Forecast-2032″ Report provides an in-depth understanding of epilepsy, historical and forecast epidemiology, and epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and the Japan.

The Epilepsy Market report provides current treatment practices, emerging drugs, epilepsy market share of individual therapies and current and forecast epilepsy market size from 2019 to 2032 segmented by seven main markets. The report also covers current epilepsy treatment practices/algorithms, market drivers, market barriers, and unmet medical needs to select the best opportunities and assess the underlying market potential.

Some of the key facts from the Epilepsy Market report:

  • According to a study entitled “Epidemiology, causes and treatment of epilepsy in sub-Saharan Africa” conducted by Ba-Diop et al., epilepsy is a common neurological disease in tropical countries, particularly in sub-Saharan Africa. The estimated prevalence from house-to-house studies was almost double that seen in Asia, Europe and North America. The most frequently implicated risk factors are birth trauma, central nervous system infections, and traumatic brain injury. The meta-analysis showed that the overall prevalence of epilepsy in sub-Saharan Africa is 9.39 per 1000. The study further reported that the prevalence was higher in house-to-house studies than in house-to-house studies. transverse. The median prevalence was 14 2 per 1000 (IQR 8 0–33 2), similar to that found in previous studies (15 4 per 1000; 5 0–74 0) and higher than in countries more developed (5 8 per 1000; 2 7–12 4). In meta-regression, as in meta-analysis, door-to-door studies found higher prevalence than cross-sectional studies (p = 0 078).
  • In a study titled “A Comprehensive Literature Review on Epilepsy in Selected Emerging Market Countries”, conducted by Angalakuditi et al., the prevalence of epilepsy was 4.0/1000 population in Saudi Arabia. The study was conducted in the period including Saudi Arabia and Arab League members (Mauritania, Morocco, Algeria, Tunisia, Libya, Egypt, Sudan, Djibouti, Comoros, Somalia, Eritrea, Lebanon, Jordan, Syria, Iraq, Saudi Arabia). Saudi Arabia, Qatar, Kuwait, United Arab Emirates, Oman, Bahrain and Yemen) and the Palestinian Territory (Gaza Strip and West Bank

Key Highlights of the Epilepsy Market Report:

  • The report covers the descriptive overview of epilepsy, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies.
  • A comprehensive overview was provided on the epidemiology and treatment of epilepsy in 7MM
  • Additionally, a comprehensive account of current and emerging therapies for epilepsy is provided, along with the assessment of new therapies, which will impact the current treatment landscape.
  • A detailed review of the epilepsy market; historical and forecast is included in the report, covering drug awareness in the 7MM
  • The report provides an edge when developing business strategies, by understanding the trends shaping and driving the global Epilepsy market

You have questions ? Click here to learn more about the Epilepsy Market Market Scenery

Overview of Epilepsy

According to the National Institute of Neurological Disorders and Stroke (NINDS), epilepsies are a spectrum of brain disorders ranging from serious, life-threatening and disabling disorders, to those that are much more benign. In epilepsy, the normal pattern of neural activity is disrupted, causing strange sensations, emotions, and behavior or sometimes seizures, muscle spasms, and loss of consciousness. According to the Epilepsy Foundation, seizures are classified as follows:

Generalized seizures – These affect both cerebral hemispheres (sides of the brain) from the onset of the seizure.

Focal seizures – These start on one side of the brain and were previously called partial seizures.

Unknown Crises – It can start as one type of crisis and then change to another.

Diagnosing the indication involves determining whether a person has a form of epilepsy and, if so, what type of seizures they have. Diagnostic tests include brain scans like computed tomography (computed tomography), PET (positron emission tomography) and MRI (magnetic resonance imaging), blood tests, and developmental, neurological, and behavioral tests.

Treatment for epilepsy involves antiepileptic drugs (AEDs) such as sodium channel blockers, calcium channel blockers, GABA A receptor agonists and others, diet therapy, and surgery.

Epidemiological overview of epilepsy:

  • According to a study titled “Epidemiology and Etiology of Epilepsy in Sub-Saharan Africa” by Preux et al., data on the incidence and prognosis of epilepsy in sub-Saharan Africa are sparse, but prevalence data show that the epilepsy is two or three times more common than in developing countries in non-tropical areas. The study further reported that the median prevalence found in door-to-door studies is 15 per 1,000 people. Moreover, the prevalence estimated by the capture-recapture method was 35 1 per 1000 (95% CI 23 3–46 9), showing that the house-to-house survey could have underestimate the true prevalence of epilepsy by up to 50%. The average sex ratio of men to women is 1.4 in studies from sub-Saharan Africa. The study also reported that when available, the onset of seizures was before age 20 in over 60% of cases. Various studies in sub-Saharan Africa have shown a predominance of generalized tonic-clonic seizures (GTCS) (~60%). The study reported that a Ugandan study found that 57 of 91 epileptic patients had generalized seizures, 22 had partial seizures and 12 had difficult-to-classify seizures.
  • Another study titled “A Review of Epilepsy Stigma in Egypt”, conducted by Shehata et al., reported that epilepsy is one of the most common neurological disorders with a worldwide prevalence of between 5 and 10 per 1000 with considerable variation between different contexts. In Egypt, the prevalence was 6.98/1,000

Epidemiological segmentation of the epilepsy market

  • Total population with prevalent epilepsy
  • Prevalent population diagnosed with epilepsy (in adults)
  • Prevalent population diagnosed by gender of epilepsy
  • Prevalent population diagnosed with epilepsy (in children)

Epilepsy Market Outlook

The Epilepsy Market outlook of the report helps to build a detailed understanding of historical, current and forecasted Epilepsy market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and obstacles, and the demand for better technology.

This segment gives a comprehensive detail of Epilepsy market trend of each marketed drug and late-stage pipeline treatment by rating their impact based on annual treatment cost, inclusion and exclusion criteria, mechanism of action, the compliance rate, the growing need of the market. , patient growth, patient segment covered, expected launch year, competition with other therapies, brand value, their impact on the market and opinion of key market leaders. opinion. The calculated market data is presented with relevant charts and graphs to give a clear view of the market at first glance.

According to DelveInsight, the 7MM epilepsy market is expected to change over the study period 2019-2032.

Learn more by requesting a sample @ Epilepsy Market Market Scenery

Epilepsy Market Drivers

• Specialized multidisciplinary care

• Constructive efforts

• Promising Emerging Therapies

• Increased research and development

• Government initiatives and funding

Barriers to the epilepsy market

• Generics on the market

• Low compliance rate

• Barrier of heterogeneity

•Differential diagnosis

• Therapeutic barriers

Key Companies in the Epilepsy Market

  • Marinus Pharmaceuticals
  • Takeda
  • UCB Pharmaceuticals
  • And much more

Epilepsy Market Therapies

  • Ganaxolone
  • Soticlestat
  • Alprazolam staccato
  • And many more


  • key ideas
  • Presentation of the report
  • Epilepsy Market Executive Summary
  • Background and overview of the disease
  • Epidemiology and patient population
  • United States
  • EU 5
  • Emerging Epilepsy Market Therapies
  • Epilepsy Market Outlook
  • Market access and reimbursement of therapies
  • Annex
  • Epilepsy Market Report Methodology
  • Features of DelveInsight
  • Disclaimer
  • About DelveInsi

Click here to learn more about Epilepsy market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Adya Kaoul
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/